OCEA (Ocean Biomedical) Equity-to-Asset: -58.41 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Ocean Biomedical Equity-to-Asset?

Ocean Biomedical OCEA Equity-to-Asset is -58.41 as of Mar. 2025.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Ocean Biomedical's Total Stockholders Equity for the quarter that ended in Mar. 2025 was $-92.40 Mil. Ocean Biomedical's Total Assets for the quarter that ended in Mar. 2025 was $1.58 Mil.

The historical rank and industry rank for Ocean Biomedical's Equity-to-Asset or its related term are showing as below:

OCEA's Equity-to-Asset is not ranked *
in the Biotechnology industry.
Industry Median: 0.69
* Ranked among companies with meaningful Equity-to-Asset only.

Ocean Biomedical  (OTCPK:OCEA) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Ocean Biomedical Equity-to-Asset Related Terms

Ocean Biomedical Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Ocean Biomedical's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ocean Biomedical Equity-to-Asset Chart

Ocean Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Equity-to-Asset
0.97 -5.87 -16.50 -108.22

Ocean Biomedical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -25.72 -50.10 -86.65 -108.22 -58.41

OCEA vs SIGY, ENDV, SCPX: Equity-to-Asset Comparison

For the Biotechnology subindustry, Ocean Biomedical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocean Biomedical Equity-to-Asset vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocean Biomedical's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Ocean Biomedical's Equity-to-Asset falls into.


Ocean Biomedical Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Ocean Biomedical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Equity to Asset (A: Dec. 2024 )=Total Stockholders Equity/Total Assets
=-97.616/0.902
=

Ocean Biomedical's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

Equity to Asset (Q: Mar. 2025 )=Total Stockholders Equity/Total Assets
=-92.399/1.582
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -58.41 mean?
Ocean Biomedical (OCEA) has a Equity-to-Asset of -58.41 as of Mar. 2025. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ocean Biomedical and its competitors.
Is Ocean Biomedical's Equity-to-Asset too high?
Ocean Biomedical's current Equity-to-Asset is -58.41.
How does Ocean Biomedical's Equity-to-Asset compare to SIGY and ENDV?
Ocean Biomedical's Equity-to-Asset of -58.41 can be compared against companies in the Biotechnology industry. The industry median Equity-to-Asset is 0.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Biotechnology company?
The median Equity-to-Asset among Biotechnology companies is 0.69, based on 1,410 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Ocean Biomedical and its competitors. For the Biotechnology industry, the median Equity-to-Asset is 0.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ocean Biomedical's current Equity-to-Asset is -58.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ocean Biomedical stock overvalued right now?
Ocean Biomedical (OCEA) has a current Equity-to-Asset of -58.41. The current Equity-to-Asset is -58.41. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Ocean Biomedical (OCEA), the current Equity-to-Asset is -58.41 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ocean Biomedical Business Description

Address 55 Claverick Street, Room 325, Providence, RI, USA, 02903
Ocean Biomedical Inc is a biopharmaceutical company that is focused on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases. The company is developing an antibody therapeutic product candidate inhibiting Chi3l1, and a bi-specific antibody product candidate inhibiting Chi3l1 plus PD-1 and CTLA-4 for the treatment of non-small cell lung cancer and glioblastoma multiforme; and a small molecule product candidate targeting Chit1 for the treatment of Idiopathic Pulmonary Fibrosis and Hermansky-Pudlak Syndrome.